+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oncology Drugs Market Research Reports

Vulvar Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Vulvar Cancer - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Anaplastic Thyroid Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Anaplastic Thyroid Cancer - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Biliary Tumor - Pipeline Insight, 2025 - Product Thumbnail Image

Biliary Tumor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 180 Pages
  • Global
From
Ewing Sarcoma - Pipeline Insight, 2025 - Product Thumbnail Image

Ewing Sarcoma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 115 Pages
  • Global
From
Metastatic Hepatocellular Carcinoma- Pipeline Insight, 2025 - Product Thumbnail Image

Metastatic Hepatocellular Carcinoma- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Hepatic Tumor - Pipeline Insight, 2025 - Product Thumbnail Image

Hepatic Tumor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 240 Pages
  • Global
From
TGF-Beta-1 Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

TGF-Beta-1 Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Inhibitor Of Apoptosis (IAP) Antagonist- Pipeline Insight, 2025 - Product Thumbnail Image

Inhibitor Of Apoptosis (IAP) Antagonist- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Tie-2 Modulators - Pipeline Insight, 2025 - Product Thumbnail Image

Tie-2 Modulators - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
4-1BB Receptor Agonist - Pipeline Insight, 2025 - Product Thumbnail Image

4-1BB Receptor Agonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 100 Pages
  • Global
From
RET (Ret Proto-Oncogene) Protein Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

RET (Ret Proto-Oncogene) Protein Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Adrenocortical Carcinoma- Pipeline Insight, 2025 - Product Thumbnail Image

Adrenocortical Carcinoma- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Adenoid Cystic Carcinoma- Pipeline Insight, 2025 - Product Thumbnail Image

Adenoid Cystic Carcinoma- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Advanced Liver Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Advanced Liver Cancer - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 180 Pages
  • Global
From
Chemotherapy Induced Neutropenia - Pipeline Insight, 2025 - Product Thumbnail Image

Chemotherapy Induced Neutropenia - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Leiomyosarcoma - Pipeline Insight, 2025 - Product Thumbnail Image

Leiomyosarcoma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Recurrent Or Metastatic Head And Neck Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Recurrent Or Metastatic Head And Neck Cancer - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Gastric Cancer- Pipeline Insight, 2025 - Product Thumbnail Image

Gastric Cancer- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 550 Pages
  • Global
From
Tenosynovial Giant Cell Tumors - Pipeline Insight, 2025 - Product Thumbnail Image

Tenosynovial Giant Cell Tumors - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 50 Pages
  • Global
From
Liver Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Liver Cancer - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 280 Pages
  • Global
From
Loading Indicator

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy. The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more